Market Price Fluctuations and Impairment Risk for Investment Securities
First written in FY2017. 7 of 14 entries say "Materialised", first in FY2019. Latest entry: FY2026.
Kawata Mfg. moved to the "Worse" side of this theme in 2020, 1 year after the typical company in this theme (2019).
The whole theme swung hardest in 2019: 66 of 142 companies on the "Worse" side.
38 other companies' latest entry also says "Other".
- FY2026Increase in fair value with no valuation lossAnnual report
「Consolidated balance-sheet carrying amount at the consolidated closing date not exceeding acquisition cost Shares — — — Total 676,137 165,320 510,817」
There were no investment securities whose value fell below acquisition cost during the fiscal year, resulting in a valuation difference of ¥510.817 million. Market price fluctuation risk remains, but no valuation loss was recognized during the fiscal year. - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The Company states that there have been no significant changes in its major risks, including the risks of market price fluctuations and impairment losses relating to investment securities. - FY2024-Q2MaterialisedAnnual report
「Under extraordinary gains and losses, a valuation loss on investment securities of ¥10 million was recognized as an extraordinary loss」
A valuation loss on investment securities of ¥10.327 million was recognized, showing that the risks of market price fluctuations and impairment losses continued to materialize. - FY2024-Q1MaterialisedAnnual report
「Under extraordinary gains and losses, a valuation loss on investment securities of ¥10 million was recognized as an extraordinary loss」
In connection with the risks of market price fluctuations and impairment losses relating to investment securities, a valuation loss on investment securities of ¥10.685 million was recognized in the first quarter. - FY2023-Q3MaterialisedAnnual report
「Under extraordinary gains and losses, a gain on sales of investment securities of ¥14 million was recognized as an extraordinary gain, while a valuation loss on investment securities of ¥11 million and a loss of ¥108 million related to the COVID-19 pandemic at a Chinese subsidiary were recognized as extraordinary losses. In addition, income taxes, including corporate, inhabitant and enterprise taxes, of ¥150 million and deferred income taxes of ¥29 million were recognized, among other factors, resulting in quarterly net income attributable to owners of the parent of ¥150 million, a decrease of ¥231 million, or 60.6%, from the same period of the previous year.」
A valuation loss on investment securities of ¥11.309 million was recognized, indicating that the risks of market price fluctuations and impairment losses materialized again in the cumulative third quarter. - FY2022-Q2WorsenedAnnual report
「Under extraordinary gains and losses, a valuation loss on investment securities of ¥10 million and a loss on liquidation of a subsidiary of ¥4 million were recognized as extraordinary losses. In addition, income taxes, including corporate, inhabitant and enterprise taxes, of ¥61 million and deferred income taxes of ¥75 million were recognized, among other factors, resulting in quarterly net income attributable to owners of the parent of ¥159 million, an increase of ¥27 million, or 20.8%, from the same period of the previous year.」
A valuation loss on investment securities of ¥10.072 million was recognized, increasing from ¥2.094 million in the second quarter of the previous fiscal year. The risks of market price fluctuations and impairment losses materialized again during the quarter. - FY2021MaterialisedAnnual report
「During the current consolidated fiscal year, impairment losses of ¥2.041 million were recognized on all holdings whose market prices had declined by 30% or more.」
The risk of a decline in the market prices of investment securities materialized again during the fiscal year, and impairment losses of ¥2.041 million were recognized. - FY2021-Q2MaterialisedAnnual report
「Under extraordinary gains and losses, a valuation loss on investment securities was recognized as an extraordinary loss in the amount of ¥2 million」
In connection with the risks of market price fluctuations and impairment losses relating to investment securities, a valuation loss on investment securities of ¥2.094 million was recognized. - FY2021-Q1MaterialisedAnnual report
「Under extraordinary gains and losses, a valuation loss on investment securities was recognized as an extraordinary loss in the amount of ¥2 million」
In connection with the risks of market price fluctuations and impairment losses relating to investment securities, a valuation loss on investment securities of ¥2 million was recognized. - FY2020-Q2RestatedAnnual report
「During the cumulative second-quarter consolidated period, there were no significant changes in the matters described in the quarterly report concerning business conditions and financial information that could materially affect investors’ decisions, or in the business risks described in the securities report for the previous fiscal year.」
The Company states that there have been no significant changes in the risks of market price fluctuations and impairment losses relating to investment securities. - FY2020-Q1RestatedAnnual report
「During the cumulative first-quarter consolidated period, there were no material changes in matters described in this quarterly report concerning the status of the business, financial information and other matters that could materially affect investors' decisions, or in the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no significant changes in the risks of market price fluctuations and impairment losses relating to investment securities. - FY2019MaterialisedAnnual report
「During the current consolidated fiscal year, impairment losses of ¥7.622 million were recognized on all holdings whose market prices had declined by 30% or more.」
The risk of a decline in the market prices of investment securities materialized, and impairment losses of ¥7.622 million were recognized. - FY2018RestatedAnnual report
「Shares classified as investment securities are exposed to market price fluctuation risk. They are held mainly in companies with which the Group has business relationships, and regularly determined fair values are reported to the Board of Directors.」
The Company continues to manage the risk of market price fluctuations affecting cross-shareholdings and other investments, including reporting fair values to the Board of Directors. - FY2017First statedAnnual report
「Shares classified as investment securities are exposed to the risk of fluctuations in market prices, but primarily consist of shares in companies with which the Company has business relationships. Fair values determined regularly are reported to the Board of Directors. For investment securities with quoted market prices, the Company recognizes impairment losses in full when fair value falls by 30% or more below acquisition cost.」
The Company recognizes the risk of market price fluctuations affecting cross-shareholdings and other investments, reports fair values to the Board of Directors, and discloses a policy of recognizing impairment losses on holdings whose market prices have declined by 30% or more.